Clinical Trial Update: Neoadjuvant Treatment of Upper Urinary and Muscular Invasive Bladder Urothelial Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 neoadjuvant trial in upper urinary tract urothelial carcinoma and muscle-invasive bladder cancer; status not provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Muscle-invasive Bladder Cancer
• Upper Tract Urothelial Carcinoma

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: Upper Tract Urinary Carcinoma, Muscle-invasive Bladder Cancer | Phase 2 | Status: UNKNOWN